Skip to main content
. 2020 Oct 10;12(10):2903. doi: 10.3390/cancers12102903

Figure 5.

Figure 5

Effect on cell proliferation (A,B) and apoptosis (C,D) after treatment of cisplatin-resistant NCCIT-R cell line with belinostat and panobinostat. (A,B) The decrease in cell proliferation determined by BrDU assay at 24, 48, and 72 h of treatment with belinostat and panobinostat; (C,D) increase in apoptosis as determined by Cell-APOPercentage at 24 h of treatment with belinostat and panobinostat. Abbreviations: DMSO—dimethyl sulfoxide. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001.